<!DOCTYPE sequence-cwu SYSTEM "us-sequence-listing-2004-03-09.dtd" [ ]>
<sequence-cwu id="SEQLST-1">
<publication-reference>
<document-id>
<country>US</country>
<doc-number>08623887</doc-number>
<kind>B2</kind>
<date>20140107</date>
</document-id>
</publication-reference>
<number>1</number>
<sequence-list-new-rules>
<s100>
<s160>3</s160>
</s100>
<s200>
<s210>1</s210>
<s211>13</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial Sequence Synthetic
      peptide</s223>
</s220>
</s200>
<s400> 1
Glu Pro Leu Glu Arg Arg Leu Ser Leu Val Pro Asp Ser
1               5                   10
</s400>
<s200>
<s210>2</s210>
<s211>13</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial Sequence Synthetic
      peptide</s223>
</s220>
</s200>
<s400> 2
Glu Pro Leu Glu Arg Arg Leu Ser Leu Val Pro Lys Met
1               5                   10
</s400>
<s200>
<s210>3</s210>
<s211>28</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial Sequence Synthetic
      peptide</s223>
</s220>
</s200>
<s400> 3
Leu Arg Arg Trp Ser Leu Gly Leu Arg Arg Trp Ser Leu Gly Leu Arg
1               5                   10                  15
Arg Trp Ser Leu Gly Leu Arg Arg Trp Ser Leu Gly
            20                  25
</s400>
</sequence-list-new-rules>
</sequence-cwu>
